- Hem
- Om universitetet
- Hitta person
- Andreas Josefsson
Andreas Josefsson
Anknuten till forskning
Avd för urologi-
Performance of 4Kscore as a Reflex Test to Prostate-specific Antigen in the GÖTEBORG-2 Prostate Cancer Screening
Trial
Andreas Josefsson, Marianne Månsson, Kimia Kohestani, Vasiliki Spyratou, Jonas Wallström, Mikael Hellström, Hans Lilja, Andrew Vickers, Sigrid Carlsson, Rebecka Arnsrud Godtman, Jonas Hugosson
EUROPEAN UROLOGY - 2024 -
Effects of a Phytoestrogen Intervention and Estrogen Receptor β Genotype on Prostate Cancer Proliferation and PSA Concentrations-A Randomized Controlled
Trial
Rebecca Ahlin , Andreas Josefsson, Sanna Nybacka, Rikard Landberg, Johan Stranne, Gunnar Steineck, Maria Hedelin
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL - 2024 -
Acoustic Enrichment of Heterogeneous Circulating Tumor Cells and Clusters from Metastatic Prostate Cancer
Patients
Cecilia Magnusson, Per Augustsson, Eva Undvall Anand, Andreas Lenshof, Andreas Josefsson, Karin Welén, Anders Bjartell, Yvonne Ceder, Hans Lilja, Thomas Laurell
Analytical Chemistry - 2024 -
Unanswered questions in prostate cancer — findings of an international multi-stakeholder consensus by the PIONEER
consortium
Muhammad Imran Omar, Steven MacLennan, Maria J. Ribal, Monique J. Roobol, Konstantinos Dimitropoulos, Thomas van den Broeck, Sara J. MacLennan, Susan Evans Axelsson, Giorgio Gandaglia, Peter Paul Willemse, Ken Mastris, John Butler Ransohoff, Zsuzsanna Devecseri, Thomas Abbott, Bertrand De Meulder, Anders Bjartell, Alex Asiimwe, James N’Dow, Emma Smith, Karin Plass, Nicolas Mottet, Robert Shepherd, Lisa Moris, Michael Lardas, Nicola Fossati, Karl Pang, Riccardo Campi, Isabella Greco, Mauro Gacci, Sergio Serni, Ragnar Lonnerbro, Alberto Briganti, Daniele Crosti, Roberto Garzonio, Martina Faticoni, Chris Bangma, Eliza Roest, Arjan Breederland, Sebastiaan Remmers, Derya Tilki, Anssi Auvinen, Teemu Murtola, Tapio Visakorpi, Kirsi Talala, Teuvo Tammela, Aino Siltari, Mieke Van Hemelrijck, Katharina Beyer, Stephane Lejeune, Laurence Colette, Simona Caputova, Delielena Poli, Sigrid van Dorp, Sophie Byrne, Luz Fialho, Ashley Rowland, Neo Tapela, Francesco Ugolini, Charles Auffray, Nesrine Taibi, Ayman Hijazy, Albert Saporta, Kai Sun, Shaun Power, Nazanin Zounemat Kermani, Kees van Bochove, Maxim Moinat, Mirella Kalafati, Azadeh Tafreshiha, Chiara Bernini, Kristina Hlavati, Denis Horgan, Louise Fullwood, Marc Holtorf, Doron Lancet, Gabi Bernstein, Sheela Tripathee, Manfred Wirth, Michael Froehner, Beate Brenner, Angelika Borkowetz, Christian Thomas, Friedemann Horn, Kristin Reiche, Markus Kreuz, Andreas Josefsson, Delila Gasi Tandefelt, Jonas Hugosson, Jack Schalken, Henkjan Huisman, Thomas Hofmarcher, Peter Lindgren, Emelie Andersson, Adam Fridhammar, Monica Tames Grijalva, Frank Verholen, Jihong Zong, Todd Williamson, Kumari Chandrawansa, Reg Waldeck
Nature Reviews Urology - 2023 -
Effect of docetaxel added to bicalutamide in Hormone-Naive non-metastatic prostate cancer with rising PSA, a randomized clinical trial
(SPCG-14)
Andreas Josefsson, Åsa Jellvert, Erik Holmberg, K. Brasso, P. M. Petersen, S. Aaltomaa, M. Luukkaa, P. Verhagen, R. de Wit, G. Ahlgren, O. Andren, E. Castellanos, M. Seke, A. Widmark, Jan-Erik Damber
Acta Oncologica - 2023 -
Effects on Serum Hormone Concentrations after a Dietary Phytoestrogen Intervention in Patients with Prostate Cancer: A Randomized Controlled
Trial.
Rebecca Ahlin , Natalja P Nørskov, Sanna Nybacka, Rikard Landberg, Viktor Skokic, Johan Stranne, Andreas Josefsson, Gunnar Steineck, Maria Hedelin
Nutrients - 2023 -
Correction: The effect of a phytoestrogen intervention and impact of genetic factors on tumor proliferation markers among Swedish patients with prostate cancer: study protocol for the randomized controlled PRODICA
trial.
Rebecca Alin, Sanna Nybacka, Andreas Josefsson, Johan Stranne, Gunnar Steineck, Maria Hedelin
Trials - 2023 -
The effect of a phytoestrogen intervention and impact of genetic factors on tumor proliferation markers among Swedish patients with prostate cancer: study protocol for the randomized controlled PRODICA
trial
Rebecca Ahlin , Sanna Nybacka, Andreas Josefsson, Johan Stranne, Gunnar Steineck, Maria Hedelin
Trials - 2022 -
Prostate Specific Antigen and Biopsy Contamination in the Goteborg-1 Randomized, Population-Based, Prostate Cancer Screening
Trial
Karin Stinesen-Kollberg, E. Holmberg, Andreas Josefsson, Jonas Hugosson, Rebecka Arnsrud Godtman
Journal of Urology - 2022 -
Reply to Carlos G. Wambier and Gerard J. Nau's Letter to the Editor re: Karin Welén, Ebba Rosendal, Magnus Gisslén, et al. A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.12.013. Positive Effects of Enzalutamide for Hospitalized COVID-19 Patients: Still No Positive Effect of Enzalutamide for Hospitalized COVID-19
Patients.
Karin Welén, Ebba Rosendal, Eva Freyhult, William K Oh, Magnus Gisslén, Clas Ahlm, Anne-Marie Fors Connolly, Anna K Överby, Andreas Josefsson
European urology - 2022 -
A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro
Data.
Karin Welén, Ebba Rosendal, Magnus Gisslén, Annasara Lenman, Eva Freyhult, Osvaldo Fonseca-Rodríguez, Daniel Bremell, Johan Stranne, Åse Östholm Balkhed, Katarina Niward, Johanna Repo, David Robinsson, Anna J Henningsson, Johan Styrke, Martin Angelin, Elisabeth Lindquist, Annika Allard, Miriam Becker, Stina Rudolfsson, Robert Buckland, Camilla Thellenberg Carlsson, Anders Bjartell, Anna C Nilsson, Clas Ahlm, Anne-Marie Fors Connolly, Anna K Överby, Andreas Josefsson
European Urology - 2022 -
Clinical and biological relevance of the transcriptomic-based prostate cancer metastasis subtypes
MetA-C
E. Thysell, L. Kohn, J. Semenas, H. Jaremo, E. Freyhult, M. Lundholm, C. T. Karlsson, Jan-Erik Damber, A. Widmark, S. Crnalic, Andreas Josefsson, Karin Welén, R. J. A. Nilsson, A. Bergh, P. Wikstrom
Molecular Oncology - 2022 -
Association between pharmaceutical modulation of oestrogen in postmenopausal women in Sweden and death due to COVID-19: a cohort
study
M. Sund, O. Fonseca-Rodriguez, Andreas Josefsson, Karin Welen, A. M. F. Connolly
BMJ Open - 2022 -
COVIDENZA - A prospective, multicenter, randomized PHASE II clinical trial of enzalutamide treatment to decrease the morbidity in patients with Corona virus disease 2019 (COVID-19): a structured summary of a study protocol for a randomised controlled
trial.
Karin Welen, Anna K Överby, Clas Ahlm, Eva Freyhult, David Robinsson, Anna Jonsson Henningsson, Johan Stranne, Daniel Bremell, Martin Angelin, Elisabeth Lindquist, Robert Buckland, Camilla Thellenberg Carlsson, Karlis Pauksens, Anna Bill-Axelsson, Olof Akre, Cecilia Ryden, Magnus Wagenius, Anders Bjartell, Anna C Nilsson, Johan Styrke, Johanna Repo, Åse Östholm Balkhed, Katarina Niward, Magnus Gisslén, Andreas Josefsson
Trials - 2021 -
Gene expression alterations during development of castration-resistant prostate cancer are detected in circulating tumor
cells
Andreas Josefsson, Karin Larsson, E. Freyhult, Jan-Erik Damber, Karin Welén
Cancers - 2020 -
Marked response to cabazitaxel in prostate cancer xenografts expressing androgen receptor variant 7 and reversion of acquired resistance by
anti-androgens
E. B. Ylitalo, E. Thysell, C. Thellenberg-Karlsson, M. Lundholm, A. Widmark, A. Bergh, Andreas Josefsson, M. Brattsand, P. Wikstrom
Prostate - 2020 -
Introducing PIONEER: a project to harness big data in prostate cancer
research.
Muhammad Imran Omar, Monique J Roobol, Maria J Ribal, Thomas Abbott, Paul-Michael Agapow, Sonia Araujo, Alex Asiimwe, Charles Auffray, Irina Balaur, Katharina Beyer, Chiara Bernini, Anders Bjartell, Alberto Briganti, John-Edward Butler-Ransohoff, Riccardo Campi, Marinel Cavelaars, Bertrand De Meulder, Zsuzsanna Devecseri, Marc Dietrich Voss, Konstantinos Dimitropoulos, Susan Evans-Axelsson, Billy Franks, Louise Fullwood, Denis Horgan, Emma Jane Smith, Amit Kiran, Kati Kivinummi, Mark Lambrecht, Doron Lancet, Peter Lindgren, Sara MacLennan, Steven MacLennan, Maria Manuela Nogueira, Fredrik Moen, Maxim Moinat, Kishore Papineni, Christian Reich, Kristin Reiche, Stijn Rogiers, Claudio Sartini, Kees van Bochove, Femke van Diggelen, Mieke Van Hemelrijck, Hein Van Poppel, Jihong Zong, James N'Dow, Delila Gasi Tandefelt, Jonas Hugosson, Andreas Josefsson
Nature reviews. Urology - 2020 -
AR-V7 expression in circulating tumor cells as a potential prognostic marker in metastatic hormone-sensitive prostate
cancer.
Andreas Josefsson, Jan-Erik Damber, Karin Welén
Acta oncologica (Stockholm, Sweden) - 2019 -
Immunoreactivity for prostate specific antigen and Ki67 differentiates subgroups of prostate cancer related to
outcome
P. Hammarsten, Andreas Josefsson, E. Thysell, M. Lundholm, C. Hägglöf, D. Iglesias-Gato, A. Flores-Morales, P. Stattin, L. Egevad, T. Granfors, P. Wikström, A. Bergh
Modern Pathology - 2019 -
Performance and inter-observer variability of prostate MRI (PI-RADS version 2) outside high-volume
centres.
Kimia Kohestani, Jonas Wallström, Niclas Dehlfors, Ole Martin Sponga, Marianne Månsson, Andreas Josefsson, Sigrid Carlsson, Mikael Hellström, Jonas Hugosson
Scandinavian journal of urology - 2019 -
Circulating tumor cells mirror bone metastatic phenotype in prostate
cancer
Andreas Josefsson, Karin Larsson, Marianne Månsson, Jens Björkman, Eva Rohlova, Daniel Åhs, Helena Brisby, Jan-Erik Damber, Karin Welén
Oncotarget - 2018 -
Circulating Tumor Cells as a Marker for Progression-free Survival in Metastatic Castration-naïve Prostate
Cancer.
Andreas Josefsson, Anna Linder, Despina Flondell Site, Giacomo Canesin, Anna Stiehm, Aseem Anand, Anders Bjartell, Jan-Erik Damber, Karin Welén
The Prostate - 2017 -
Automated Bone Scan Index as a quantitative imaging biomarker in metastatic castration-resistant prostate cancer patients being treated with
enzalutamide.
Aseem Anand, Michael J Morris, Steven M Larson, David Minarik, Andreas Josefsson, John T Helgstrand, Peter S Oturai, Lars Edenbrandt, Martin Andreas Røder, Anders Bjartell
EJNMMI research - 2016 -
TMPRSS2-ERG Expression Predicts Prostate Cancer Survival and Associates with Stromal
Biomarkers
C. Hagglof, P. Hammarsten, K. Stromvall, L. Egevad, Andreas Josefsson, P. Stattin, T. Granfors, A. Bergh
Plos One - 2014 -
High density of S100A9 positive inflammatory cells in prostate cancer stroma is associated with poor
outcome.
Viktor Tidehag, Peter Hammarsten, Lars Egevad, Torvald Granfors, Pär Stattin, Tomas Leanderson, Pernilla Wikström, Andreas Josefsson, Christina Hägglöf, Anders Bergh
European journal of cancer (Oxford, England : 1990) - 2014 -
Tumour epithelial expression levels of endocannabinoid markers modulate the value of endoglin-positive vascular density as a prognostic marker in prostate
cancer.
Christopher J Fowler, Andreas Josefsson, Lina Thors, Sui Chu Chung, Peter Hammarsten, Pernilla Wikström, Anders Bergh
Biochimica et biophysica acta - 2013 -
Nuclear Stat5a/b predicts early recurrence and prostate cancer-specific death in patients treated by radical
prostatectomy.
Tuomas Mirtti, Benjamin E Leiby, Junaid Abdulghani, Elina Aaltonen, Miia Pavela, Anita Mamtani, Kalle Alanen, Lars Egevad, Torvald Granfors, Andreas Josefsson, Par Stattin, Anders Bergh, Marja T Nevalainen
Human pathology - 2013 -
The Study of Active Monitoring in Sweden (SAMS): A randomized study comparing two different follow-up schedules for active surveillance of low-risk prostate
cancer.
Ola Bratt, Stefan Carlsson, Erik Holmberg, Lars Holmberg, Eva Johansson, Andreas Josefsson, Annika Nilsson, Maria Nyberg, David Robinsson, Jonas Sandberg, Dag Sandblom, Pär Stattin
Scandinavian journal of urology - 2013 -
Low endoglin vascular density and Ki67 index in Gleason score 6 tumours may identify prostate cancer patients suitable for
surveillance.
Andreas Josefsson, Pernilla Wikström, Lars Egevad, Torvald Granfors, Lars Karlberg, Pär Stattin, Anders Bergh
Scandinavian journal of urology and nephrology - 2012 -
Phospho-Akt immunoreactivity in prostate cancer: relationship to disease severity and outcome, Ki67 and phosphorylated EGFR
expression.
Peter Hammarsten, Mariateresa Cipriano, Andreas Josefsson, Pär Stattin, Lars Egevad, Torvald Granfors, Christopher J Fowler
PloS one - 2012 -
LRIG1 and the liar paradox in prostate cancer: a study of the expression and clinical significance of LRIG1 in prostate
cancer.
Marcus Thomasson, Baofeng Wang, Peter Hammarsten, Anna Dahlman, Jenny Liao Persson, Andreas Josefsson, Pär Stattin, Torvald Granfors, Lars Egevad, Roger Henriksson, Anders Bergh, Håkan Hedman
International journal of cancer. Journal international du cancer - 2011 -
Prostate cancer increases hyaluronan in surrounding nonmalignant stroma, and this response is associated with tumor growth and an unfavorable
outcome.
Andreas Josefsson, Hani Adamo, Peter Hammarsten, Torvald Granfors, Pär Stattin, Lars Egevad, Anna Engström Laurent, Pernilla Wikström, Anders Bergh
The American journal of pathology - 2011 -
Low levels of phosphorylated epidermal growth factor receptor in nonmalignant and malignant prostate tissue predict favorable outcome in prostate cancer
patients.
Peter Hammarsten, Amar Karalija, Andreas Josefsson, Stina Häggström Rudolfsson, Pernilla Wikström, Lars Egevad, Torvald Granfors, Pär Stattin, Anders Bergh
Clinical cancer research : an official journal of the American Association for Cancer Research - 2010 -
Stromal PDGFRbeta expression in prostate tumors and non-malignant prostate tissue predicts prostate cancer
survival.
Christina Hägglöf, Peter Hammarsten, Andreas Josefsson, Pär Stattin, Janna Paulsson, Anders Bergh, Arne Ostman
PloS one - 2010 -
A high cannabinoid CB(1) receptor immunoreactivity is associated with disease severity and outcome in prostate
cancer.
Sui Chu Chung, Peter Hammarsten, Andreas Josefsson, Pär Stattin, Torvald Granfors, Lars Egevad, Giacomo Mancini, Beat Lutz, Anders Bergh, Christopher J Fowler
European journal of cancer (Oxford, England : 1990) - 2009 -
Tumor size, vascular density and proliferation as prognostic markers in GS 6 and GS 7 prostate tumors in patients with long follow-up and non-curative
treatment.
Andreas Josefsson, Pernilla Wikström, Torvald Granfors, Lars Egevad, Lars Karlberg, Pär Stattin, Anders Bergh
European urology - 2005